GSA Capital Partners LLP Has $131,000 Holdings in Viemed Healthcare, Inc. (NASDAQ:VMD)

GSA Capital Partners LLP raised its stake in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 37.1% in the third quarter, Holdings Channel.com reports. The firm owned 17,836 shares of the company’s stock after buying an additional 4,829 shares during the period. GSA Capital Partners LLP’s holdings in Viemed Healthcare were worth $131,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in VMD. Evernest Financial Advisors LLC bought a new position in shares of Viemed Healthcare during the second quarter valued at about $66,000. Perkins Coie Trust Co bought a new position in shares of Viemed Healthcare during the 3rd quarter worth approximately $73,000. Victory Capital Management Inc. boosted its stake in shares of Viemed Healthcare by 21.1% in the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after buying an additional 2,226 shares during the last quarter. SG Americas Securities LLC purchased a new position in shares of Viemed Healthcare in the 3rd quarter worth approximately $89,000. Finally, Price T Rowe Associates Inc. MD bought a new position in shares of Viemed Healthcare in the first quarter valued at approximately $97,000. 74.24% of the stock is owned by institutional investors.

Insider Activity

In related news, Director Nitin Kaushal sold 30,000 shares of the business’s stock in a transaction on Monday, November 11th. The stock was sold at an average price of $9.56, for a total transaction of $286,800.00. Following the sale, the director now directly owns 126,843 shares in the company, valued at approximately $1,212,619.08. The trade was a 19.13 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $9.28, for a total transaction of $336,502.08. Following the completion of the sale, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. The trade was a 25.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 20.00% of the company’s stock.

Viemed Healthcare Stock Performance

Shares of Viemed Healthcare stock opened at $8.65 on Tuesday. The business’s fifty day simple moving average is $8.49 and its 200 day simple moving average is $7.56. The company has a current ratio of 1.31, a quick ratio of 1.19 and a debt-to-equity ratio of 0.03. Viemed Healthcare, Inc. has a 12 month low of $6.21 and a 12 month high of $10.44. The firm has a market capitalization of $336.83 million, a P/E ratio of 32.85 and a beta of 1.43.

Viemed Healthcare (NASDAQ:VMD) last announced its earnings results on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.08 by $0.02. The firm had revenue of $58.00 million during the quarter. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.